#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transplant rejection Osteomyelitis Retinal artery occlusion Myelin oligodendrocyte glycoprotein antibody-associated disease White matter lesion Infertility female Wolfram syndrome Alternating hemiplegia of childhood Noonan syndrome Retinal dystrophy Neuromyelitis optica spectrum disorder Lung adenocarcinoma Congenital growth hormone deficiency Ovarian cancer stage IV Waldenstrom's macroglobulinaemia refractory More trials…

    Learn about Rare Diseases

    Malignant fibrous histiocytoma – Diagnostics Familial amyotrophic lateral sclerosis – Diagnostics Burkitt’s lymphoma Proteus syndrome – Diagnostics Hepatoblastoma – Life with Disease Myelodysplastic syndrome with excess blasts Nephrotic syndrome – Life with Disease Ehlers-Danlos syndrome Haemolytic uraemic syndrome – Trials in Disease Lennox-Gastaut syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Escitalopram Oxalate Brigatinib Rosuvastatin SAROGLITAZAR HEMIMAGNESIUM Thiamine Nitrate Caffeine Danicopan Oxygen Ph.eur. Doxribtimine Iptacopan Hydrochloride MB-001 Dexamethasone Indometacin Ph. Eur. Argipressin GSKVX000000040033 Mps-103 Nebivolol Hydrochloride Resiquimod Sulfate Progesterone, Micronised Catequentinib Dihydrochloride More therapies…

    Learn about Your Condition

    Pemphigoid Arterial stiffness Spinal pain Haemolytic uraemic syndrome Post procedural infection Chronic lymphocytic leukaemia Precocious puberty Meningorrhagia Pleomorphic leiomyosarcoma Ependymoma malignant Cutibacterium acnes infection Uterine leiomyosarcoma Osteoporosis Microvillous inclusion disease Adrenogenital syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study testing fitusiran to prevent bleeding in boys aged 1 to 11 years with hemophilia A or B with or without inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia
    Investigated Drugs:
    • Fitusiran
    Belgium Germany Hungary Italy Poland Romania +1

  • Study of Trastuzumab Deruxtecan and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Who Have Not Received Prior Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Pertuzumab
    • Trastuzumab Deruxtecan
    France Germany Spain

  • A Study Testing if Daily Tadalafil Improves Movement Symptoms in Patients with Early-Stage Parkinson’s Disease Who Have Not Yet Started Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Tadalafil
    The Netherlands

  • Orforglipron for stress urinary incontinence in women with obesity or overweight

    Recruiting

    3 1
    Investigated Diseases:
    • Stress
    • Urinary incontinence
    Czechia Poland Romania

  • A Study of Tenecteplase for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    Germany

  • A Study of Intravenous Lidocaine to Reduce Inflammation in Patients Undergoing Heart Valve or Coronary Artery Bypass Surgery with Heart-Lung Machine

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac valve disease
    • Coronary artery disease
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Sodium Chloride
    Spain
Previous Page
1 … 93 94 95 96 97 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!